FDA Approves Erivedge for Basal Cell Carcinoma
Links shared publicly online about this topic.
- 0total visits
FDA Approves Erivedge for Basal Cell Carcinoma
View full resource at drugs.com
Tags: Cancer, Skin Cancer, Basal Cell Carcinoma, FDA
Most Recently Shared on January 30, 2012 at 8:10 pm By:
FDA Approves Erivedge for Basal Cell Carcinoma - http://t.co/eHgzlEfZ
FDA Approves First US Treatment for Advanced Basal Cell Carcinoma - SkinCancer.org
skincancer.org — “FDA Approves First US Treatment for Advanced Basal Cell Carcinoma - SkinCancer.org” View full resource at skincancer.org
Most Recently Shared on February 1, 2012 at 10:46 pm By:
SkinCancerFoundation Health Organization and Dermatology
FDA Approves First US Treatment for Advanced Basal Cell Carcinoma http://t.co/oDhklA42
Skin Cancer Drug Erivedge Approved
webmd.com — “The FDA has approved Erivedge, a once-daily pill that can shrink disfiguring or metastatic basal cell carcinoma (BCC) tumors.” View full resource at webmd.com
Most Recently Shared on January 31, 2012 at 7:38 pm By:
Skin Cancer Drug Erivedge Approved
webmd.com — “The FDA has approved Erivedge, a once-daily pill that can shrink disfiguring or metastatic basal cell carcinoma (BCC) tumors.” View full resource at webmd.com
Most Recently Shared on January 31, 2012 at 6:50 pm By:
Skin Cancer Drug Erivedge Approved: The FDA has approved Erivedge, a once-daily pill that can shrink disfiguring... http://t.co/vM5TFhLC
New skin cancer drug approved – - CNN.com Blogs
thechart.blogs.cnn.com — “Adults with metastatic basal cell cancer now have a new drug to help them battle the disease. The Food and Drug Administration has approved Erivedge under the agency's priority review program.” View full resource at thechart.blogs.cnn.com
Most Recently Shared on January 31, 2012 at 3:56 pm By:
New skin cancer drug approved – - http://t.co/NoAYKP1T Blogs http://t.co/fM6sIqXx via @cnn
FDA Approves New Skin Cancer Drug | Healthland | TIME.com
healthland.time.com — “Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma. The pill is called Erivedge and is made by Genentech, a unit of Swiss drugmaker Roche.” View full resource at healthland.time.com
Most Recently Shared on January 31, 2012 at 2:28 pm By:
FDA approves new skin cancer drug | http://t.co/3jkUXY8z
FDA Approves Drug For Common Skin Cancer
medicalnewstoday.com — “On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's ge” View full resource at medicalnewstoday.com
Most Recently Shared on January 31, 2012 at 10:05 am By:
FDA Approves Drug For Common Skin Cancer: On Monday, the US Food and Drug Administration approved a new type of ... http://t.co/i0MgRPKx
FDA Approves Erivedge for Basal Cell Carcinoma
drugs.com — “Erivedge (vismodegib) is used to treat basal cell carcinoma. Includes Erivedge side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 30, 2012 at 9:12 pm By:
Drugs and Devices OW OW Health
FDA Approves Erivedge for Basal Cell Carcinoma: SILVER SPRING, Md., Jan. 30, 2012 /PRNewswire-USNewswire/ ... http://t.co/IgWMnxTt #drug
FDA approves first drug for metastatic basal cell carcinoma | HemOncToday
hemonctoday.com — “FDA approves first drug for metastatic basal cell carcinoma | HemOncToday” View full resource at hemonctoday.com
Most Recently Shared on January 30, 2012 at 9:07 pm By:
HemOnc Today Oncology and Health News
FDA approves vismodegib for the treatment of adults with basal cell carcinoma: http://t.co/Yl35XCgo
F.D.A. Approves Drug for an Advanced Skin Cancer - NYTimes.com
prescriptions.blogs.nytimes.com — “The drug, Erivedge, made by Genentech, was approved for adults with basal cell carcinoma that has spread elsewhere in the body or those who are not candidates for surgery or radiation.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 30, 2012 at 8:48 pm By:
F.D.A. Approves Drug for an Advanced Skin Cancer http://t.co/JMn8oA89
First Drug Ok'd to Combat Spreading Basal Cell Skin Cancer - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration on Monday approved a drug to treat the most common form of skin cancer, basal cell carcinoma. Erivedge (vismodegib) is the” View full resource at drugs.com
Most Recently Shared on January 30, 2012 at 8:05 pm By:
Drugs and Devices OW OW Health
First Drug Ok'd to Combat Spreading Basal Cell Skin Cancer: MONDAY, Jan. 30 -- The U.S. Food and Drug Admi... http://t.co/qcHSy8Q4 #drug
Erivedge Approved to Treat Basal Cell Carinoma - Drugs.com MedNews
drugs.com — “Erivedge (vismodegib) has been approved by the U.S. Food and Drug Administration to treat the most common form of skin cancer, basal cell carcinoma, the agency” View full resource at drugs.com
Most Recently Shared on January 30, 2012 at 8:05 pm By:
Drugs and Devices OW OW Health
Erivedge Approved to Treat Basal Cell Carinoma: MONDAY, January 30 -- Erivedge (vismodegib) has been appro... http://t.co/XbEC40oe #drug
FDA approves Roche skin cancer drug | Reuters
reuters.com — “(Reuters) - U.S. health regulators on Monday approved Roche's pill to treat an advanced form of the most common form of skin cancer, known as basal cell carcinoma.The drug, Erivedge, which was co-developed” View full resource at reuters.com
Most Recently Shared on January 30, 2012 at 6:06 pm By:
FDA approves Roche skin cancer drug http://t.co/DOHN8nHz
FDA approves new treatment for most common type of skin cancer
fda.gov — “Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).” View full resource at fda.gov
Most Recently Shared on January 30, 2012 at 4:27 pm By:
FDA approves Genentech's Erivedge for basal cell carcinoma.. once daily pill inhibits Hedgehog pathway.. http://t.co/LrK0JbVd #pharma
Genentech: Newsroom: Press Releases: News Release January 30, 2012
gene.com — “Genentech News Release - FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma” View full resource at gene.com
Most Recently Shared on January 30, 2012 at 4:13 pm By:
New #Genentech medicine is 1st #FDA - approved medicine for adults w/ advanced basal cell carcinoma http://t.co/p4EDeaNB
Advertisement
